SOPHiA GENETICS S.A. (SOPH) Research

SOPHiA GENETICS S.A. operates as a specialized company within the healthcare technology sector. The firm provides the SOPHiA DDM platform, a cloud-native Software-as-a-Service (SaaS) solution engineered to analyze diverse multimodal datasets and various diagnostic inputs, thereby extracting valuable insights. This platform, together with its related offerings and services, is widely adopted by hospitals, laboratories, and biopharmaceutical organizations across the globe. Founded in 2011, SOPHiA GENETICS S.A. is headquartered in Saint-Sulpice, Switzerland.

Market snapshot

Symbol
SOPH
Price
$5.46
Day change
+4.20%
Market cap
$391.3M
P/E ratio
-4.80x
52-week range
2.59-5.7
Sector
Healthcare
Industry
Medical - Healthcare Information Services
Next earnings
in 2 months
Analyst price target
$7.50

Recent news

  • Sophia Genetics, Ormat Technologies And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

    U.S. stock futures were mostly higher this morning, with the Nasdaq futures gaining over 100 points on Wednesday.

Peer companies

  • AC Immune S.A. (ACIU)
  • Agilon Health, Inc. (AGL)
  • Alto Neuroscience, Inc. (ANRO)
  • Cellectis S.A. (CLLS)
  • Definitive Healthcare Corp. (DH)
  • Larimar Therapeutics, Inc. (LRMR)
  • Nakamoto Inc. (NAKA)
  • National Research Corporation (NRC)

Recent insider activity

  • Xu Zhenyu — S-Sale (4000 shares) on 2026-06-15
  • Menu Philippe — S-Sale (5000 shares) on 2026-06-12
  • Camblong Jurgi — S-Sale (8500 shares) on 2026-06-10
  • CARDOZA GEORGE — P-Purchase (20000 shares) on 2026-06-05
  • Menu Philippe — S-Sale (5000 shares) on 2026-05-26

Open SOPHiA GENETICS S.A. (SOPH) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.